 |
市場調查報告書
商品編碼
1190079
生物材料傷口敷料市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)Biomaterial Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內，生物材料傷口敷料市場的複合年增長率預計為 11.2%。
COVID-19 大流行嚴重影響了醫療保健行業，包括生物材料傷口敷料部分。 此外，COVID-19 大流行影響了全球經濟，也對全球醫院為非 COVID-19 患者提供的綜合醫院護理的運作產生了重大影響。 例如，AJMC 於 2021 年 9 月發表的一篇論文發現，在 COVID-19 流行期間，相當一部分慢性傷口患者延遲了預防性和緊急傷口護理。我在這裡。 COVID-19 大流行期間的此類延誤對所研究市場的增長產生了負面影響。 然而，解除限制有望重啟傷口治療服務，在預測期內刺激生物材料傷口敷料市場的增長。
生物材料傷口敷料市場受到技術進步、人口老齡化、慢性傷口和問題負擔增加以及與傳統傷口癒合治療相關的副作用的推動。 此外，政府舉措的增加、對慢性傷口迅速和安全治療的需求、生活方式障礙的流行，如導致靜脈性腿部潰瘍、壓力性潰瘍和糖尿病性腿部潰瘍的糖尿病，都在推動市場增長。 例如，根據國際糖尿病聯合會的 IDF 糖尿病地圖集第十版 2021，2021 年全球有超過 5.37 億成年人患有糖尿病。 同一份文件還報告說，全球糖尿病患者人數到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。 預計容易患足部潰瘍的糖尿病患者數量增加將促進研究市場的增長。
致力於傷口管理的公共衛生項目的擴展也有望刺激市場增長。 例如，在 2022 年 5 月由國家傷口護理戰略計劃主辦的網絡研討會上，主持人討論了許多不同的治療腿部靜脈潰瘍的方法。 預期市場的擴大將受益於旨在提高公眾對傷口護理服務意識的舉措。
然而，高昂的治療費用和不利的報銷政策是阻礙市場增長的一些因素。
主要市場趨勢
海藻酸鹽塗料預計在預測期內佔很大份額
藻酸鹽敷料是一種輕質無紡布天然傷口敷料，由可促進癒合的高吸水性材料製成。 廣泛用於液體過多的創傷。 藻酸鹽敷料通常由種子樹製成，因此具有很強的吸收性，可以提供適合治療乾燥傷口的濕潤傷口環境。
此外，藻酸鹽敷料適用於治療流血的傷口，並通過保持神經末梢濕潤來減輕疼痛。 因此，它適用於治療大量出血的傷口、手術傷口、一度和二度燒傷以及供體部位，並可能在預測期內推動該領域的增長。
由於其親水性，海藻酸被廣泛用於傷口癒合。 例如，2021 年 9 月發表在 Personalized Medicine 上的一篇論文表明，與其他生物材料相比，藻酸鹽是最常見的具有傷口癒合特性的生物材料。 藻酸鹽傷口敷料因其親水性而廣泛應用於珠子、混合物、敷料、電紡支架、柔性纖維、薄膜、泡沫、凝膠、水凝膠、注射劑、微粒、微球、納米粒子、聚電解質複合材料。 、粉末、繩索、床單和海綿，用於創傷後和滲出的傷口。 海藻酸鹽敷料的廣泛應用有望在預測期內促進研究領域的增長。
此外，近年來關於使用藻酸鹽敷料治療慢性傷口癒合的研究不斷增加。 例如，2021 年 6 月發表在 F1000Res. 上的一篇論文表明，含有沒食子酸的藻酸鹽生物膜可有效用於治療具有低度至中度膿液的慢性傷口。 因此，在預測期內，改進對藻酸鹽敷料的研究有望推動該細分市場的增長。
預計在預測期內北美將佔據很大的市場份額
北美生物材料傷口敷料市場預計將在全球佔有重要的市場份額。 推動該地區市場的主要因素是適應快速老齡化社會的先進醫療體系、高糖尿病人口和創新。
糖尿病患者人數的增加是市場增長的主要推動力。 例如，根據 2022 年 1 月更新的全國糖尿病統計報告，美國約有 3730 萬人患有糖尿病，約佔總人口的 11.3%。 另據報導，美國約有 9600 萬 18 歲及以上的人處於糖尿病前期。 此外，根據美國糖尿病協會 2022 年 2 月更新的統計數據，美國估計有 283,000 名 20 歲以下的人被診斷患有糖尿病，約佔其中的 35%。
此外，根據國際糖尿病聯合會的數據，到 2021 年，加拿大將有超過 290 萬年齡在 20 至 79 歲之間的人患有糖尿病。 數據指出，到2040年，日本糖尿病患者人數將增至約350萬。 在北美地區，預計容易患足部潰瘍的糖尿病患者人數會增加，從而增加對創新傷口敷料技術的需求，預計這將在預測期內刺激市場增長。
此外，主要市場參與者的存在及其在新產品發布和研發方面的活動預計將推動該地區的市場增長。
競爭格局
生物材料傷口敷料市場是一個高度分散且競爭激烈的市場。 3M、ConvaTec Group PLC、Molnlycke Health Care AB、Smith & Nephew PLC 和 B. Braun Melsungen AG 等主要市場參與者在該行業中佔有重要份額。 大多數市場參與者都專注於將先進的產品推向市場以獲取最大的市場份額。
其他福利。
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第一章介紹
- 研究假設和市場定義
- 調查範圍
第二章研究方法論
第 3 章執行摘要
第四章市場動態
- 市場概覽
- 市場驅動力
- 增加慢性傷口和相關疾病的負擔
- 傷口護理方面的政府舉措
- 市場製約因素
- 缺乏適當的報銷
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第五章市場細分（價值基礎，單位：百萬美元）
- 按產品分類
- 水膠體
- 海藻酸覆蓋材料
- 皮膚替代品
- 其他產品
- 通過使用
- 傷口
- 伯恩斯
- 潰瘍
- 其他用途
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東和非洲
- 海灣合作委員會
- 南非
- 其他中東和非洲地區
- 南美洲地區
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章競爭格局
- 公司簡介
- 3M
- ConvaTec Group PLC
- DermaRite Industries LLC
- B. Braun Melsungen AG
- Hollister Incorporated
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Medtronic PLC
- Molnlycke Health Care AB
- Smith & Nephew PLC
第7章 市場機會與今後動向
The biomaterial wound dressing market is expected to register a CAGR of 11.2% during the forecast period.
The COVID-19 pandemic severely affected the healthcare sector, including the biomaterial wound dressing segment. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals globally. For instance, according to an article published by the AJMC in September 2021, a significant percentage of patients with chronic wounds had delayed preventative and emergent wound care during the COVID-19 pandemic. Such delays during the COVID-19 pandemic negatively impacted the growth of the studied market. However, with the restrictions being lifted, wound care services have been resumed, which is expected to add to the growth of the biomaterial wound dressing market over the forecast period.
The biomaterial wound dressing market is driven by advancements in technology, a growing ageing population, the rising burden of chronic wounds and problems, and side effects associated with conventional wound healing procedures. Furthermore, an increase in government initiatives, demand for fast and safe treatment for chronic wounds, and an increase in the prevalence of lifestyle disorders such as diabetes leading to venous leg ulcers, pressure ulcers, and diabetic foot ulcers propels the growth of the market. For instance, according to the International Diabetes Federation's IDF Diabetes Atlas Tenth edition 2021, over 537 million adults in the world were living with diabetes in the year 2021. The source also reported that the number of diabetic people in the world would increase to 643 million by 2030 and 783 million by 2045. The rising number of people affected by diabetes, who are more susceptible to foot ulcers is expected to boost the growth of the studied market.
The expansion of public health programs devoted to wound management is also anticipated to fuel market expansion. During a webinar hosted by the National Wound Care Strategy Programme in May 2022, for instance, presenters discussed a number of different approaches to healing venous leg ulcers. The expansion of the examined market is anticipated to benefit from initiatives aimed at raising public awareness of wound care services.
However, the high cost of treatment and unfavorable reimbursement policies are the few factors that hinder the market growth.
Key Market Trends
Alginate Dressing is Anticipated Have Significant Share in the Forecast Period
Alginate dressing refers to light, non-woven natural wound dressings that are composed of highly absorbent materials and promote healing. These are widely used in exudent wounds, where there is excess fluid. Alginate dressing is usually made from seed wood thus, highly absorbent and providing a moist wound environment that is favorable for treating dry injuries.
Furthermore, alginate dressing is suitable to treat bleeding wounds and keep nerve endings moist reducing pain. This makes them preferable in treating heavily draining wounds, surgical wounds, first and second-degree burns, and in donor sites, this is likely to fuel the segment growth over the forecast period.
Alginate is widely used in wound healing properties owing to its hydrophilic nature. For instance, according to an article published in the journal of Personalized Medicine in September 2021, alginate is the most common biomaterial with wound-healing properties, when compared to other biomaterials. The alginate wound dressing can take up multiple forms such as beads, blends, dressings, electrospun scaffolds, flexible fibers, films, foams, gels, hydrogels, injections, microparticles, microspheres, nanoparticles, polyelectrolyte complex, powders, ropes, sheets, sponges, and others due to its hydrophilic nature, and are thus used on post-traumatic wounds or exuding wounds. Such wide application of the alginate dressing is expected to boost the growth of the studied segment over the forecast period.
Moreover, the research on the use of alginate dressing for chronic wound healing has also been on the rise in recent years. For example, an article published in F1000Res. in June 2021 indicated that gallic acid-incorporated alginate biofilm could be efficiently used for the treatment of low to medium-suppurating chronic wounds. Thus, the improved research on alginate dressings is expected to propel the growth of the market segment over the forecast period.
North America Expected to have Significant Market Share in the Forecast Period
North America's biomaterial wound dressing market is projected to have a significant market share worldwide. Major factors that are driving the market in the region are a rapidly growing aging population, a high diabetic population, and the developed healthcare system, which adapts to novel innovations.
The increasing number of people affected by diabetes is a major factor contributing to the market growth. For instance, according to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in United States have diabetes, which equates to around 11.3% of the total population. Also, the report stated that around 96 million people aged 18 years or older in United States have prediabetes. Moreover, as per the American Diabetes Association Statistics updated in February 2022, about 283,000 people in United States under the age of 20 are estimated to have been diagnosed with diabetes, approximately 35% of that population.
Also, as per the International Diabetes Federation, in 2021, over 2.9 million people in Canada in the age group of 20-79 years were found to be affected by diabetes. The same source indicated that by 2040, the number of people with diabetes in the nation would rise up to around 3.5 million. The rising diabetic population in the North American region, who are more susceptible to foot ulcers, is expected to increase the demand for innovative wound dressing technologies, which is likely to add to the market growth over the forecast period.
Moreover, the presence of key market players coupled with their activity in the launching of new products and R&D are expected to bolster the market growth in the region.
Competitive Landscape
The biomaterial wound dressing market is moderately fragmented and competitive. The major market players, such as 3M, ConvaTec Group PLC, Molnlycke Health Care AB, Smith & Nephew PLC, and B. Braun Melsungen AG, hold a significant market share in the industry. Most of the market players are focusing on bringing advanced products in the market to acquire the maximum market share.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
- 4.2.2 Government Initiatives Regarding Wound Care Treatment
- 4.3 Market Restraints
- 4.3.1 Lack of Proper Reimbursement
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)
- 5.1 By Product
- 5.1.1 Hydrocolloids
- 5.1.2 Alginate Dressing
- 5.1.3 Skin Substitutes
- 5.1.4 Other Products
- 5.2 By Application
- 5.2.1 Wounds
- 5.2.2 Burns
- 5.2.3 Ulcers
- 5.2.4 Other Applications
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 3M
- 6.1.2 ConvaTec Group PLC
- 6.1.3 DermaRite Industries LLC
- 6.1.4 B. Braun Melsungen AG
- 6.1.5 Hollister Incorporated
- 6.1.6 Integra LifeSciences Holdings Corporation
- 6.1.7 Johnson & Johnson
- 6.1.8 Medtronic PLC
- 6.1.9 Molnlycke Health Care AB
- 6.1.10 Smith & Nephew PLC
